History Timeline

See Our History year by year!
2001
  • Preparation of operational methods for Regulatory and Quality Control Departments
2002 ~ 2003
  • Preparation of the primary Site Master File
  • Preparation of validation drafts for Water Making System and Injectable Vials Manufacturing Line
  • Setting up a 15-square meter fat freeze dryer
2004 ~ 2005
  • Operation of injectable vial line and manufacturing the production of first Pepticare batch
  • IRFDA CGMP first Audit – IRFDA GMP Certificate
  • Receiving manufacturing permission for Ronulin N and R
2006 ~ 2007
  • Setting up Quality Assurance Department
  • Registration of Desfonak in Vietnam
  • IRFDA first audit for pre-filled syringes lines
  • Receiving manufacturing permission for Ciprox 200
  • Receiving manufacturing permission for Desfonak 500
  • Receiving manufacturing permission for Medrolin 500
  • Receiving manufacturing permission for Pepticare 40
  • Receiving manufacturing permission for Rofolin 30
  • Receiving manufacturing permission for Rofolin 200
2008 ~ 2009
  • Laboratories Calibration
  • IRFDA audit for Insulin lines
  • Preparation of the second phase of validation for Water Making System
  • First media fill of injectable vials
  • Receiving manufacturing permission for Rolexan 4000
  • Receiving manufacturing permission for Granisetron
2010 ~ 2011
  • Preparation of the third phase of validation for Water Making System
  • Takeda first audit
  • Receiving manufacturing permission for Rolexan 6000
  • Receiving manufacturing permission for Ropakin 400
  • Receiving manufacturing permission for Zolena
2012 ~ 2013
  • IRFDA CGMP Audit – IRFDA GMP Certificate renewal
  • Receiving manufacturing permission for Glamer 20 Injection
  • Receiving manufacturing permission for Gonarex
  • Receiving manufacturing permission for Menotron
  • Receiving manufacturing permission for Ronal F
  • Takeda Audit
2014 ~ 2015
  • Receiving manufacturing permission for Glamer 40 PFS
  • Receiving manufacturing permission for Takeda Pantazole 20 tablet
  • Receiving manufacturing permission for Takeda Pantazole 40 tablet
  • Receiving manufacturing permission for Takeda Pantazole 40 injection vial
  • Receiving manufacturing permission for Ronulin N and R
  • Receiving manufacturing permission for Roviro 250
  • IRFDA CGMP Audit – IRFDA GMP Certificate
2016 ~ 2017
  • Receiving manufacturing permission for Colistimethate Sodium 1 M IU
  • Receiving manufacturing permission for Protamine Sulphate
  • Receiving manufacturing permission for Rofend 200
  • Receiving manufacturing permission for Rofolin 100
  • Secondary Packaging of Takeda Pantazole
  • ISO 9001 Training programme
  • IRFDA GMP Certificate
  • Purchasing machineries for the expansion plan
  • Addition of Gonarex, Menotron, Glamer, Roniscan and Ronal F
  • Preparation of infrastructures for the expansion of sterile lines and solid dosage manufacturing
  • IRFDA GMP Certificate renewal
  • Addition of Colistimethate Sodium 1 MU, Decarelin 0.1 mg, Cetronax 0.25 mg
  • IRFDA GMP Certificate
    Secondary Packaging of Takeda Pantazole
    Addition of Gonarex, Menotron and Ronal F
2018 ~ 2019
  • Receiving manufacturing permission for Desfonak 2 g
  • Setting up new manufacturing line for injectable products leading to 100 and 200 percent increase respectively for lyophilised and solution vials
  • Operation of new manufacturing line for injectable products
  • IRFDA GMP Certificate renewal
  • Setting up lines for manufacturing tablets and capsules
  • Uganda MoH GMP Certificate
  • Recruiting 60 new employees
  • Reaching the record of manufacturing over 13 million vials and pre-filled syringes
  • IRFDA CGMP Audit – IRFDA GMP Certificate
  • Ugandan NDA CGMP Audit – Ugandan GMP Certificate
  • Setting up new manufacturing line for injectable products
  • Addition of Colistimethate Sodium 1 MU, Decarelin 0.1 mg, Cetronax 0.25 mg